ADVANCED DIAGNOSTIC SOLUTIONS
Industry-Leading Laboratory Technologies And Services
CLS Labs provides advanced diagnostic solutions for personalized medicine, infectious disease programs, and COVID-19 testing. CLS Labs technologies include advanced molecular diagnostics platforms, next generation sequencing capabilities, and high throughput sample processing capabilities. CLS Labs has proven its expertise and the scalability of its platforms for thousands of client groups including large national health systems, municipalities, long-term care organizations, employers, pharmacists, and providers.
COVID-19 Diagnostic Solutions
COVID-19 Infection Testing
CLS Labs offers a range of high-accuracy, fast-turnaround COVID-19 diagnostic solutions to meet the demanding needs of clinical providers, employers, care facilities, and municipalities. Laboratory COVID-19 PCR tests quickly identify the SARS-CoV-2 virus so effective actions can begin sooner, and CLS Labs supports testing workflows for surveillance, compliance, and outbreak containment. CLS Labs suite of software solutions facilitates streamlined test ordering, sample logistics, and reporting. CLS provides high-quality clinical-grade RT-PCR tests that are compliant with the FDA’s in-effect policy guidance for COVID-19 testing performed by CLIA-certified laboratories.
COVID-19 Antibody
CLS Lab provides both laboratory-based and high-quality rapid COVID-19 Antibody test solutions as a complement to infection testing programs. The CLS Lab based antibody tests provide fast turnaround, high-quality serology results that can aid clinicians in their assessment of infected and recovered patients. Antibody tests are compliant with the FDA’s in-effect policy guidance for COVID-19 testing performed by CLIA-certified laboratories.
Infectious Disease Diagnostics
%20Panel.png)
Pharmacogenomics And Personalized Medication Management (PGx)
CLS Labs Pharmacogenomics solutions utilize the latest in high-quality evidence based-science to maximize clinical impact and empower clinical decision support. CLS Labs offers a range of panels and program designs to benefit combinatorial medication risk assessments, specialty medication analysis, and clinical research programs.
Hereditary Cancer Testing (CGx)
The CLS Labs Hereditary Cancer (CGx) screening assay analyzes causative variants involved in some of the most common hereditary cancers with relatively high population occurrences. This molecular diagnostics program enables clinical providers and patients to make proactive decisions about prevention options, lifestyle choices, and potential therapies.
Personalized Diagnostics
Gastrointestinal Pathogen Panel (GI)
The CLS Labs Gastrointestinal Pathogen Panel quickly identifies several enteropathogenic viruses, bacteria, and parasites responsible for gastroenteritis by utilizing multiplex quantitative Real-time PCR. It precisely detects the pathogens during single or coinfections and identifies antibiotic drug resistance in one single test. It also facilitates antibiotic stewardship by pinpointing situations for which antibiotics should be avoided.
Urinary Tract Infection Panel
Urinary tract infections (UTIs) are the most common infections requiring medical attention and a leading justification for antibiotic prescription. CLS molecular diagnostic test accurately detects uropathogens and improves treatment selection while preserving antibiotic stewardship. These enhancements in both speed and accuracy compared with traditional detection methods improve the clinical decisioning process, drive lower overall care costs and readmits, improve outcomes, and creating operational efficiencies for the healthcare team.
Wound Pathogen Panel (WPP)
The CLS Labs Wound Pathogen Panel (WPP) rapidly establishes the microbiological profile of a sample and simultaneously reveals antibiotic resistance genes. This diagnostic uses a molecular-based analysis platform that provides enhanced precision and speed for species identification when compared to conventional cultures.
Personalized Diagnostics
Advanced Toxicology Screening
Toxicology screens are typically used to identify chemicals, drugs, or toxins that may impact a patient’s health or plan of care. CLS Lab’s toxicology screening programs are molecular-based diagnostics that support both traditional urinalysis and simplified oral samples to rapidly identify the presence of target substances. Oral samples are especially useful for patients that are unable to urinate at the time of testing or for facilities that require gender-neutral specimen collection.
